1) Welcome to our new #accredited #tweetorial on #mechanismofaction & impact of meds commonly used in patients with or at risk for #DKD progression: #MRAs, #GLP-1 receptor agonists & #DPP-4 inhibitors. I am Sophia Ambruso DO, @sophia_kidney, from @CU_Kidney....
Let's learn more about diabetic kidney disease (#DKD)! Join us for a new #tweetorial launching tomorrow & earn 0.5h CE/CME! Expert faculty @edgarvlermamd #medtwitter #Pharmacist #insulin #SGLT2 #diabetesmanagement #kidneydisease #diabetickidneydisease...
1) Welcome to a new series on the fundamentals of #CKD in the patient with #T2D. This #accredited #tweetorial series is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals Inc & Eli Lilly Company and is intended for healthcare providers.—...
. . . covering management of hyperglycemia in DKD, delaying the progression of DKD, and evolving renal guidelines. Remember protect your kidneys, save your heart! #MedTwitter #cardiotwitter #Nephpearls @goKDIGO pic.twitter.com/PhTUMQlUUz— @CKD_ce (@ckd_ce) November...